compared to about 16% of those taking Wegovy, the AP reported, citing the study. Researchers explained in the study that ...

Clinical trial participants who took tirzepatide, the drug sold as Zepbound, lost an average of 50 pounds (22.8 kilograms) ...

compared with about 16% of Wegovy users. In both groups, weight loss was about 6% lower in men than in women, AP said. Both groups saw health improvements in blood pressure, blood sugar and blood ...

Diet and exercise tend to benefit men much more than women when ... which are sold under the brand names Wegovy and Zepbound for weight loss. Roughly 750 people with obesity were randomly split ...

compared to about 16% of those taking Wegovy, the study found. Weight loss was about 6% lower in men than in women in both groups, the authors noted. As participants in both groups lost more ...

compared to about 16% of those taking Wegovy, the AP reported, citing the study. Researchers explained in the study that weight loss was about 6% lower in men than in women in both groups ...

compared to about 16% of those taking Wegovy, the study found. Weight loss was about 6% lower in men than in women in both groups, the authors noted. As participants in both groups lost more ...

For Wegovy, that was either 1.7 or 2.4 milligrams. For Zepbound, it was 10 or 15 milligrams. And here’s what researchers found. For weight loss ... more weight than men. On average, men lost ...